In vitro activities of oxazolidinones U-100592 and U-100766 against penicillin-resistant and cephalosporin-resistant strains of Streptococcus pneumoniae

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 4, 1996, Pages 1039-1040

  Mason Jr , Edward O ^a,b   Lamberth, Linda B ^b   Kaplan, Sheldon L ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; EPEREZOLID; IMIPENEM; LINEZOLID; OXAZOLIDINONE DERIVATIVE; PENICILLIN DERIVATIVE; RIFAMPICIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; CHILD; DRUG SENSITIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MINIMUM INHIBITORY CONCENTRATION; NOTE; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

EID: 0029922958     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.4.1039     Document Type: Note

References (14)

1. Block, S. L., C. J. Harrison, J. A. Hedrick, R. D. Tyler, R. A. Smith, E. Keegan, and S. A. Chartrand. 1995. Penicillin-resistant Streptococcus pneumoniae in acute otitis media: risk factors, susceptibility patterns and antimicrobial management Pediatr. Infect. Dis. J. 14:751-759.
2. Brickner, S. J., D. K. Hutchinson, M. R. Barbachyn, S. A. Garmon, et al. 1995. Synthesis of U-100592 and U-100766, two new oxazolidinonc antibacterial agents in clinical trials for treatment of multiple-resistant gram-positive infections, abstr. F208, p 149. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
3. Duchin, J. S., R. F. Breiman, A. Diamond, H. B. Lipman, S. L. Block, J. A. Hedrick, R. Finger, and J. A. Elliott. 1995. High prevalence of multidrug-resistant Streptococcus pneumontae among children in a rural Kentucky community Pediatr Infect. Dis. J. 14:745-750.
4. Friedland, I. R. 1995 Comparison of the response to antimicrobial therapy of penicillin-resistant and penicillin-susceptible pneumococcal disease. Pediatr. Infect. Dis. J. 14:885-890.
5. Friedland, I. R., and G. R. Istre. 1992. Management of penicillin-resistant pneumococcal infections. Pediatr. Infect Dis. J. 11:433-435.
6. Friedland, I. R., S. Shelton, M. Paris, S. Rinderknecht, S. Ehrett, K. Krisher, and G. H. McCracken, Jr. 1993 Dilemmas m diagnosis and management of cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr. Infect. Dis. J 12:196-200
7. Klugman, K. P. 1990. Pneumococcal resistance to antibiotics. Clin. Microbiol. Rev. 3:171-196.
8. Klugman, K. P. 1994. Management of antibiotic-resistant pneumococcal infections. J. Antimicrob. Chemother. 34:191-193.
9. Martin, I. J., and P. T. Daley-Yates. 1995. The melabolism and kinetics of a novel oxazolidinone, U-100592, abstr. F222, p. 151. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
10. McCracken, G. H., Jr. 1995. Emergence of resistant Streptococcus pneumonias a problem in pediatrics Pediatr. Infect. Dis J. 14:424-428
11. National Committee for Clinical Laboratory Standards. 1993. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 3rd ed. Approved standard M7-A3 National Committee for Clinical Laboratory Standards, Villanova, Pa.
12. Pawsey, S. D., J. D. Harry, and D. J. Stalker. 1995. 1st administration of a new oxazolidinone antibiotic (U-100592) to man, abstr. F225, p. 152. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy American Society for Microbiology, Washington, D C.
13. Tan, T. Q., E. O. Mason, Jr., and S. L. Kaplan. 1992. Systemic infections due to Streptococcus pneumoniae relatively resistant to penicillin in a children's hospital. clinical management and outcome. Pediatrics 90:928-933.
14. Zurenko, G. E., B. H. Yagi, R. D. Schaadt, J. W. Allison, D. K. Hutchinson, M. R Barbachyn, and S. J. Brickner. 1995. In vitro antibacterial activity of U-100592 and U-100766, novel oxazolidinone antibiotics, abstr. F216. p. 150. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy American Society for Microbiology, Washington, D.C.